No wonder this share got dumped. We will understand how investors lost interest. Those others like Bintai and Solution will go crazy and smart people make good money.
DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.
The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.
"the only company in Malaysia equipped with capacity, logistics technology and network, reachability to all health facilities in Malaysia." Not true. I suppose Zuellig Pharma should sit there and look pretty.
Note: This deal is cutting out the middle men and third parties. If there is a lot of screaming and pain, they are making the noise.
KJ announcement the government procurement of the vaccine is under direct negotiations { not thru any third parties} ie. PIZFER and Covax program. Whereas private parties vaccine procurement have no link with his ministries procurement
Even for private market not any Tom and Harry company can do. U néed import permit, NPRA approval, GDP, cold chain facilities etc etc. Vaccine and not vitamin.
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
""the only company in Malaysia equipped with capacity, logistics technology and network, reachability to all health facilities in Malaysia." Not true. I suppose Zuellig Pharma should sit there and look pretty.
Note: This deal is cutting out the middle men and third parties. If there is a lot of screaming and pain, they are making the noise."
Zuellig Pharma (you may want to name others as well? such as DKSH, YSP, CCM) is huge, but would not beat Pharmaniaga.. Let's think further.. Whether Zuellig or Pharmaniage is the appointed 'grab driver' from KKM to public health facilities (Gov Hosp, KK, etc).. Who has the logistic network with capability to reach the most remote areas in Malaysia (example deep Borneo areas without land connection). At this point in time only Pharmaniaga has this capacity in Malaysia, they have been supporting KKM logistically for decades. Zuellig may be huge regionally, but not the case when we are talking about Malaysia landscape.
Yes absolutely right.. KKM can ink deals with any innovator pharma companies, no role for Pharmaniaga to do bottling or manufacturing (I have never expected this to happen, anyways), but there is no means that the giant pharma supplier could distribute for us. KKM still needs to leverage on capable hands for nationwide delivery. This is a highly specialized cold chain process, which cannot be handled by POSLAJU. This involves logistical services during the implementation.
Kanger International Bhd has roped in Zuellig Pharma Sdn Bhd and K-Star Sport Ltd to collaborate on the distribution of Covid-19 vaccines in Malaysia.
The vaccine and other products are developed by state-owned China National Pharmaceutical Group Corp (Sinopharm).
In a filing with Bursa Malaysia today, Kanger said it has entered into a memorandum of understanding (MoU) with Zuellig Pharma, the largest vaccine distributor in Malaysia and in Asia, to facilitate the import, warehousing and distribution of Covid-19 vaccines in Malaysia.
Separately, Kanger announced that it has also entered into an MoU with K-Star to appoint the latter as the sales agent of Covid-19 vaccines for private clinics in Malaysia.
Kanger said both MoUs will add value to the group as it is now focused on expanding its business into the healthcare industry, which includes the distribution of Covid-19 vaccines, and is looking for a well-established logistics and distribution provider.
Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.
“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.
“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.
SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.
FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar
(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.
The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.
"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
MQ Trader 460 views | 2 d ago
0:17
New IPO: An enterprise IT solutions provider that provides implementation services, maintenance, support and professional services, Vetece Holdings Bhd aims to list on the Ace Market!
MQ Trader 565 views | 6 d ago
0:17
New IPO: A manufacturing and trading of biomass fuel products, particularly PKS and wood pellets company, Elridge Energy Holdings Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
NPRA1985
3,415 posts
Posted by NPRA1985 > 2020-12-02 23:42 | Report Abuse
Janssen seeks Health Canada approval for its COVID-19 vaccine
https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173